In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...

In a report released yesterday, Michael Dahl from RBC Capital maintained a Sell rating on DR Horton (DHI – Research Report), with a price ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $14.13 which represents a decrease of $-0.64 or -4.33% from the prior close of $14.77. The stock opened at $14.89 and touched a low ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...

U.S. stock-trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $15.54 which represents a slight increase of $0.54 or 3.60% from the prior close of $15. The stock opened at $15.17 and touched ...

Goldman Sachs and Macquarie have emerged as the top mergers and acquisitions (M&A) financial advisers in the metals and ...

The Municipal Securities Rulemaking Board Thursday announced the members of its 2025 advisory groups, including those tapped for a new group that will focus on the intersection of technological ...